Self-replicating alphavirus RNA vaccines

Informa UK Limited - Tập 14 Số 2 - Trang 177-194 - 2015
Karl Ljungberg1, Peter Liljeström
1Department of Microbiology, Tumor- and Cell Biology Karolinska Institutet Stockholm Sweden

Tóm tắt

Từ khóa


Tài liệu tham khảo

Liu MA, 2010, Immunity, 33, 504, 10.1016/j.immuni.2010.10.004

Liu MA, 2010, Curr Opin Mol Ther, 12, 86

10.1111/j.1600-065X.2010.00980.x

10.1126/science.1690918

Fynan EF, 1993, Proc Natl Acad Sci USA, 90, 11478, 10.1073/pnas.90.24.11478

10.1038/356152a0

10.1126/science.8456302

10.1073/pnas.90.9.4156

10.1177/2051013613508729

Villarreal DO, 2013, Expert Rev Vaccines, 12, 537, 10.1586/erv.13.33

10.4161/hv.25893

Dupuy LC, 2009, Expert Rev Vaccines, 8, 1739, 10.1586/erv.09.132

Ulmer JB, 2006, Current opinion in HIV and AIDS, 1, 309, 10.1097/01.COH.0000232346.08285.a8

10.1016/S0065-2660(05)55002-8

10.1006/mthe.2000.0079

Ulmer JB, 1996, Curr Opin Immunol, 8, 531, 10.1016/S0952-7915(96)80042-2

Ulmer JB, 1996, Curr Opin Biotechnol, 7, 653, 10.1016/S0958-1669(96)80078-4

Davis BS, 2001, J Virol, 75, 4040, 10.1128/JVI.75.9.4040-4047.2001

Garver KA, 2005, Dis Aquat Organ, 64, 13, 10.3354/dao064013

10.2460/ajvr.72.12.1631

10.1016/j.vaccine.2005.07.068

Sardesai NY, 2011, Curr Opin Immunol, 3, 421, 10.1016/j.coi.2011.03.008

Ulmer JB, 2012, Vaccine, 30, 4414, 10.1016/j.vaccine.2012.04.060

10.1002/eji.1830230749

Carralot JP, 2004, Cell Mol Life Sci, 61, 2418, 10.1007/s00018-004-4255-0

Conry RM, 1995, Cancer Res, 55, 1397

10.1111/j.0105-2896.2004.00139.x

Granstein RD, 2000, J Invest Dermatol, 114, 632, 10.1046/j.1523-1747.2000.00929.x

10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-#

Johanning FW, 1995, Nucleic Acids Res, 23, 1495, 10.1093/nar/23.9.1495

Kreiter S, 2011, Curr Opin Immunol, 23, 399, 10.1016/j.coi.2011.03.007

Kreiter S, 2010, Cancer Res, 70, 9031, 10.1158/0008-5472.CAN-10-0699

Qiu P, 1996, Gene Ther, 3, 262

Roesler E, 2009, J Allergy Clin Immunol, 124, 1070, 10.1016/j.jaci.2009.06.036

Weiss R, 2012, Expert Rev Vaccines, 11, 55, 10.1586/erv.11.168

Zhou WZ, 1999, Hum Gene Ther, 10, 2719, 10.1089/10430349950016762

10.1517/17425247.2014.901308

10.1016/j.smim.2013.05.001

Pascolo S, 2004, Expert Opin Biol Ther, 4, 1285, 10.1517/14712598.4.8.1285

Pascolo S, 2006, Methods Mol Med, 127, 23

10.4161/hv.25181

10.4161/rna.22269

Petsch B, 2012, Nat Biotechnol, 30, 1210, 10.1038/nbt.2436

Fotin-Mleczek M, 2012, J Gene Med, 14, 428, 10.1002/jgm.2605

Fotin-Mleczek M, 2011, J Immunother, 34, 1, 10.1097/CJI.0b013e3181f7dbe8

Liljeström P, 1991, J Virol, 65, 4107, 10.1128/JVI.65.8.4107-4113.1991

Rice CM, 1987, J Virol, 61, 3809, 10.1128/JVI.61.12.3809-3819.1987

Davis NL, 1989, Virology, 171, 189, 10.1016/0042-6822(89)90526-6

Skoging U, 1996, Structure, 4, 519, 10.1016/S0969-2126(96)00058-5

Skoging-Nyberg U, 2000, Arch Virol, 145, 1225, 10.1007/s007050070121

Zhao H, 1994, EMBO J, 13, 4204, 10.1002/j.1460-2075.1994.tb06740.x

Bredenbeek PJ, 1993, J Virol, 67, 6439, 10.1128/JVI.67.11.6439-6446.1993

Frolova E, 1997, J Virol, 71, 248, 10.1128/JVI.71.1.248-258.1997

Kääriäinen L, 1987, J Cell Sci, 7, 231, 10.1242/jcs.1987.Supplement_7.17

Levis R, 1987, Proc Natl Acad Sci USA, 84, 4811, 10.1073/pnas.84.14.4811

Levis R, 1986, Cell, 44, 137, 10.1016/0092-8674(86)90492-7

Thomson M, 1994, Virology, 199, 354, 10.1006/viro.1994.1133

Tsiang M, 1985, J Virol, 54, 38, 10.1128/JVI.54.1.38-44.1985

Weiss B, 1989, J Virol, 63, 5310, 10.1128/JVI.63.12.5310-5318.1989

Xiong C, 1989, Science, 243, 1188, 10.1126/science.2922607

Liljeström P, 1991, Nat Biotechnol, 9, 1356, 10.1038/nbt1291-1356

Pushko P, 1997, Virology, 239, 389, 10.1006/viro.1997.8878

Berglund P, 1993, Nat Biotechnol, 11, 916, 10.1038/nbt0893-916

Frolov I, 1997, J Virol, 71, 2819, 10.1128/JVI.71.4.2819-2829.1997

Smerdou C, 1999, Curr Opin Mol Ther, 1, 244

Smerdou C, 1999, J Virol, 73, 1092, 10.1128/JVI.73.2.1092-1098.1999

Polo JM, 1999, Proc Natl Acad Sci USA, 96, 4598, 10.1073/pnas.96.8.4598

10.1073/pnas.1209367109

10.1016/0264-410X(94)90074-4

10.3390/vaccines1030367

Johansson DX, 2012, PLoS One, 7, e29732, 10.1371/journal.pone.0029732

Knudsen ML, 2014, Methods Mol Biol, 1121, 147, 10.1007/978-1-4614-9632-8_13

Berglund P, 1998, Nat Biotechnol, 16, 562, 10.1038/nbt0698-562

Dubensky TW, 1996, J Virol, 70, 508, 10.1128/JVI.70.1.508-519.1996

Ljungberg K, 2007, J Virol, 81, 13412, 10.1128/JVI.01799-07

Hariharan MJ, 1998, J Virol, 72, 950, 10.1128/JVI.72.2.950-958.1998

10.1128/JVI.01926-14

Knudsen ML, 2012, J Virol, 86, 4082, 10.1128/JVI.06535-11

10.1038/emi.2013.54

Heeney JL, 2000, J Med Primatol, 29, 268, 10.1034/j.1600-0684.2000.290320.x

Koopman G, 2004, J Gen Virol, 85, 2915, 10.1099/vir.0.80226-0

Michelini Z, 2004, J Med Primatol, 33, 251, 10.1111/j.1600-0684.2004.00076.x

Rosenwirth B, 1999, J Med Primatol, 28, 195, 10.1111/j.1600-0684.1999.tb00270.x

10.1016/S0264-410X(02)00219-0

10.1128/JVI.02533-09

Xu R, 2006, AIDS Res Hum Retroviruses, 22, 1022, 10.1089/aid.2006.22.1022

Gomez CE, 2007, Vaccine, 25, 1969, 10.1016/j.vaccine.2006.11.051

Hanke T, 2003, J Gen Virol, 84, 361, 10.1099/vir.0.18738-0

Rosario M, 2010, Eur J Immunol, 40, 1973, 10.1002/eji.201040344

Rollier C, 2005, J Infect Dis, 192, 920, 10.1086/432517

Lin Y, 2008, J Virol, 82, 7492, 10.1128/JVI.02743-07

Näslund TI, 2007, J Immunol, 178, 6761, 10.4049/jimmunol.178.11.6761

10.1053/j.seminoncol.2012.02.013

Walczak M, 2011, Mol Pharm, 8, 65, 10.1021/mp1002043

Sun Y, 2010, Vet Immunol Immunopathol, 137, 20, 10.1016/j.vetimm.2010.04.005

Zhao HP, 2009, Vet Immunol Immunopathol, 131, 158, 10.1016/j.vetimm.2009.04.003

Bhardwaj N, 2010, PLoS Negl Trop Dis, 4, e725, 10.1371/journal.pntd.0000725

Jiang G, 2009, PLoS One, 4, e6559, 10.1371/journal.pone.0006559

Penttilä T, 2004, Vaccine, 22, 3386, 10.1016/j.vaccine.2004.02.032

Palmowski MJ, 2002, J Immunol, 168, 4391, 10.4049/jimmunol.168.9.4391

Barefoot B, 2008, Vaccine, 26, 6108, 10.1016/j.vaccine.2008.09.007

Sanchez-Puig JM, 2013, PLoS One, 8, e75574, 10.1371/journal.pone.0075574

Sun Y, 2011, Vaccine, 29, 8364, 10.1016/j.vaccine.2011.08.085

Sun Y, 2013, Vaccine, 31, 538, 10.1016/j.vaccine.2012.11.013

Edelman R, 2000, Am J Trop Med Hyg, 62, 681, 10.4269/ajtmh.2000.62.681

McClain DJ, 1998, J Infect Dis, 177, 634, 10.1086/514240

Pittman PR, 1996, Vaccine, 14, 337, 10.1016/0264-410X(95)00168-Z

Kinney RM, 1993, J Virol, 67, 1269, 10.1128/JVI.67.3.1269-1277.1993

Burke DS, 1977, J Infect Dis, 136, 354, 10.1093/infdis/136.3.354

Harrison VR, 1971, J Immunol, 107, 643, 10.4049/jimmunol.107.3.643

DeMeio JL, 1979, Asian J Infect Dis, 3, 119

Levitt NH, 1986, Vaccine, 4, 157, 10.1016/0264-410X(86)90003-4

Hoke CH, 2012, Vaccine, 30, 6713, 10.1016/j.vaccine.2012.08.025

Gorchakov R, 2012, J Virol, 86, 6084, 10.1128/JVI.06449-11

10.1093/infdis/jiu014

Reisler RB, 2012, Vaccine, 30, 7271, 10.1016/j.vaccine.2012.09.049

Berglund P, 1999, Vaccine, 17, 497, 10.1016/S0264-410X(98)00224-2

Uematsu Y, 2012, Clin Vaccine Immunol, 19, 991, 10.1128/CVI.00031-12

Wecker M, 2012, Clin Vaccine Immunol, 19, 1651, 10.1128/CVI.00258-12

Bernstein DI, 2009, Vaccine, 28, 484, 10.1016/j.vaccine.2009.09.135

Hallengärd D, 2014, J Virol, 88, 2858, 10.1128/JVI.03453-13

Slovin SF, 2013, Vaccine, 31, 943, 10.1016/j.vaccine.2012.11.096

Morse MA, 2010, J Clin Invest, 120, 3234, 10.1172/JCI42672

Chen M, 2002, J Immunol, 169, 3208, 10.4049/jimmunol.169.6.3208

Caley IJ, 1997, J Virol, 71, 3031, 10.1128/JVI.71.4.3031-3038.1997

Harrington PR, 2002, J Virol, 76, 730, 10.1128/JVI.76.2.730-742.2002

10.1016/S0264-410X(00)00042-6

Khalil SM, 2014, J Virol, 88, 9182, 10.1128/JVI.00327-14

10.1128/JVI.01351-07

Thompson JM, 2008, J Immunol, 181, 574, 10.4049/jimmunol.181.1.574

Tonkin DR, 2010, Vaccine, 28, 3238, 10.1016/j.vaccine.2010.02.010

10.1128/JVI.02223-14

Hidmark AS, 2005, J Virol, 79, 10376, 10.1128/JVI.79.16.10376-10385.2005

Hidmark AS, 2006, J Virol, 80, 7100, 10.1128/JVI.02579-05

Konopka JL, 2007, PLoS Pathog, 3, e199, 10.1371/journal.ppat.0030199

Konopka JL, 2009, J Virol, 83, 12432, 10.1128/JVI.00564-09

Pollard C, 2013, Mol Ther, 21, 251, 10.1038/mt.2012.202

Mattijssen S, 2012, Microbes Infect Institut Pasteur, 14, 419, 10.1016/j.micinf.2011.11.015

Teng TS, 2012, J Clin Invest, 122, 4447, 10.1172/JCI63120

Saitoh T, 2011, Immunity, 34, 352, 10.1016/j.immuni.2011.03.010

Knudsen ML, 2013, PLoS One, 8, e65964, 10.1371/journal.pone.0065964

10.1186/1743-422X-8-36

10.1038/nm813

Caskey M, 2011, J Exp Med, 208, 2357, 10.1084/jem.20111171

Jensen S, 2012, J Virol, 86, 2900, 10.1128/JVI.05738-11

10.1038/nature09737

Scheel B, 2004, Eur J Immunol, 34, 537, 10.1002/eji.200324198

10.1074/jbc.M310175200

Wang Y, 2011, Immunol Rev, 243, 74, 10.1111/j.1600-065X.2011.01049.x

Pichlmair A, 2007, Immunity, 27, 370, 10.1016/j.immuni.2007.08.012

10.1038/nature03326

Diebold S, 2010, Immunol Lett, 128, 17, 10.1016/j.imlet.2009.09.010

Diebold SS, 2009, Gene Ther, 16, 359, 10.1038/gt.2008.164

10.1002/embj.201386117

Leitner WW, 2001, Curr Pharm Des, 7, 1641, 10.2174/1381612013397249

10.1126/science.1132998

Rehwinkel J, 2010, J Clin Immunol, 30, 491, 10.1007/s10875-010-9384-7

Hoffmann J, 2013, Curr Opin Immunol, 25, 1, 10.1016/j.coi.2013.01.008

10.1016/j.cell.2010.01.022

Carroll TD, 2011, Vaccine, 29, 931, 10.1016/j.vaccine.2010.11.024

LoBue AD, 2009, J Virol, 83, 3212, 10.1128/JVI.01650-08

10.1016/j.vaccine.2013.11.101

Thompson JM, 2008, Vaccine, 26, 4267, 10.1016/j.vaccine.2008.05.046

Tonkin DR, 2012, Vaccine, 30, 4532, 10.1016/j.vaccine.2012.04.030

Donati C, 2013, Ann N Y Acad Sci, 1285, 115, 10.1111/nyas.12046

10.1038/nature12966

Dormitzer PR, 2012, Nat Rev Microbiol, 10, 807, 10.1038/nrmicro2893

10.1126/science.1225416

10.1016/j.smim.2013.05.003

10.1038/ni.2789

Koff WC, 2013, Science, 340, 1232910, 10.1126/science.1232910

Koff WC, 2014, Nat Immunol, 15, 589, 10.1038/ni.2871

Reddy JR, 1999, Comp Immunol Microbiol Infect Dis, 22, 231, 10.1016/S0147-9571(99)00014-4

Li N, 2011, Immunopharmacol Immunotoxicol, 33, 211, 10.3109/08923971003782327

Ying H, 1999, Nat Med, 5, 823, 10.1038/10548

Vidalin O, 2000, Virology, 276, 259, 10.1006/viro.2000.0566

Brand D, 1998, AIDS Res Hum Retroviruses, 14, 1369, 10.1089/aid.1998.14.1369

Giraud A, 1999, J Virol Methods, 79, 75, 10.1016/S0166-0934(99)00009-9

10.1016/S0264-410X(01)00026-3

Fleeton MN, 2001, J Infect Dis, 183, 1395, 10.1086/319857

Hsu KF, 2001, Gene Ther, 8, 376, 10.1038/sj.gt.3301408

Andersson C, 2001, Scand J Immunol, 54, 117, 10.1046/j.1365-3083.2001.00951.x

Andersson C, 2000, FEMS Immunol Med Microbiol, 29, 247, 10.1111/j.1574-695X.2000.tb01530.x

10.1089/dna.2005.24.317

Lachman LB, 2001, Cancer Gene Ther, 8, 259, 10.1038/sj.cgt.7700300

Wang X, 2005, Breast Cancer Res, 7, R580, 10.1186/bcr1199

Pasetti MF, 2009, J Virol, 83, 2789, 10.1128/JVI.02191-08

10.1128/CVI.00045-08

Leslie MC, 2007, Gene Ther, 14, 316, 10.1038/sj.gt.3302864

Kirman JR, 2003, Infect Immun, 71, 575, 10.1128/IAI.71.1.575-579.2003

Saxena S, 2008, Vaccine, 26, 6592, 10.1016/j.vaccine.2008.09.055

Garcia-Hernandez Mde L, 2008, Cancer Res, 68, 861, 10.1158/0008-5472.CAN-07-0445

Kamrud KI, 1999, Virology, 263, 209, 10.1006/viro.1999.9961

Cabrera A, 2009, Immunobiology, 214, 467, 10.1016/j.imbio.2008.11.016

Lyons JA, 2007, Gene Ther, 14, 503, 10.1038/sj.gt.3302889

10.3171/jns.2003.99.4.0746

Yamanaka R, 2001, Cancer Gene Ther, 8, 796, 10.1038/sj.cgt.7700367

Yamanaka R, 2002, J Neurosurg, 97, 611, 10.3171/jns.2002.97.3.0611

Zhang J, 1997, Gene Ther, 4, 367, 10.1038/sj.gt.3300409

Brinster C, 2002, J Gen Virol, 83, 369, 10.1099/0022-1317-83-2-369

Ip PP, 2014, Mol Ther, 22, 881, 10.1038/mt.2013.287

Berglund P, 1997, AIDS Res Hum Retroviruses, 13, 1487, 10.1089/aid.1997.13.1487

Sundbäck M, 2005, Virology, 341, 190, 10.1016/j.virol.2005.07.017

Daemen T, 2000, Gene Ther, 7, 1859, 10.1038/sj.gt.3301257

Daemen T, 2002, Gene Ther, 9, 85, 10.1038/sj.gt.3301627

Daemen T, 2004, Antivir Ther, 9, 733, 10.1177/135965350400900515

Riezebos-Brilman A, 2009, Vaccine, 27, 701, 10.1016/j.vaccine.2008.11.032

Zhou X, 1995, Proc Natl Acad Sci USA, 92, 3009, 10.1073/pnas.92.7.3009

Smyth JW, 2005, Gene Ther, 12, 147, 10.1038/sj.gt.3302390

Fleeton MN, 2000, J Gen Virol, 81, 749, 10.1099/0022-1317-81-3-749

Fleeton MN, 1999, J Gen Virol, 80, 1189, 10.1099/0022-1317-80-5-1189

Morris-Downes MM, 2001, Vaccine, 19, 3877, 10.1016/S0264-410X(01)00126-8

Colombage G, 1998, Virology, 250, 151, 10.1006/viro.1998.9357

Colmenero P, 2002, Int J Cancer, 98, 554, 10.1002/ijc.10184

Colmenero P, 1999, Gene Ther, 6, 1728, 10.1038/sj.gt.3301004

Chen Q, 2004, Vaccine, 22, 2701, 10.1016/j.vaccine.2004.02.015

Krasemann S, 1999, J Biotechnol, 73, 119, 10.1016/S0168-1656(99)00115-7

Negri DR, 2004, J Gen Virol, 85, 1191, 10.1099/vir.0.79794-0

Nilsson C, 2001, Vaccine, 19, 3526, 10.1016/S0264-410X(01)00034-2

Mossman SP, 1996, J Virol, 70, 1953, 10.1128/JVI.70.3.1953-1960.1996

Quetglas JI, 2012, Mol Ther, 20, 1664, 10.1038/mt.2012.56

Quetglas JI, 2012, Gene Ther, 19, 271, 10.1038/gt.2011.99

Thomas JM, 2009, Clin Vaccine Immunol, 16, 1696, 10.1128/CVI.00173-09

Gupta S, 2005, J Virol, 79, 7135, 10.1128/JVI.79.11.7135-7145.2005

Gupta S, 2006, AIDS Res Hum Retroviruses, 22, 993, 10.1089/aid.2006.22.993

Perri S, 2003, J Virol, 77, 10394, 10.1128/JVI.77.19.10394-10403.2003

Cheng WF, 2006, Cancer Gene Ther, 13, 873, 10.1038/sj.cgt.7700956

10.1016/j.vaccine.2003.07.003

Tsuji M, 1998, J Virol, 72, 6907, 10.1128/JVI.72.8.6907-6910.1998

Pugachev KV, 1995, Virology, 212, 587, 10.1006/viro.1995.1516

Pan CH, 2010, J Virol, 84, 3798, 10.1128/JVI.01566-09

Pan CH, 2005, Proc Natl Acad Sci USA, 102, 11581, 10.1073/pnas.0504592102

Greer CE, 2007, Scand J Immunol, 66, 645, 10.1111/j.1365-3083.2007.02019.x

Greer CE, 2007, Vaccine, 25, 481, 10.1016/j.vaccine.2006.07.048

Heise MT, 2009, Epidemiol Infect, 137, 1309, 10.1017/S0950268808001696

Gipson CL, 2003, Vaccine, 21, 3875, 10.1016/S0264-410X(03)00307-4

Loy JD, 2013, Virol J, 10, 35, 10.1186/1743-422X-10-35

Thornburg NJ, 2007, Virology, 362, 441, 10.1016/j.virol.2007.01.001

10.1016/j.vaccine.2014.05.053

White LJ, 2007, J Virol, 81, 10329, 10.1128/JVI.00512-07

10.1128/JVI.02298-12

10.1371/journal.ppat.1003723

Herbert AS, 2013, J Virol, 87, 4952, 10.1128/JVI.03361-12

10.1016/S0264-410X(00)00113-4

Wilson JA, 2001, Virology, 286, 384, 10.1006/viro.2001.1012

10.1128/JVI.75.6.2660-2664.2001

10.1016/S0264-410X(01)00485-6

Defang GN, 2010, Vaccine, 29, 212, 10.1016/j.vaccine.2010.10.053

Mok H, 2008, J Virol, 82, 11410, 10.1128/JVI.01688-08

Velders MP, 2001, Cancer Res, 61, 7861

Bosworth B, 2010, Comp Immunol Microbiol Infect Dis, 33, e99, 10.1016/j.cimid.2010.05.002

Hubby B, 2007, Vaccine, 25, 8180, 10.1016/j.vaccine.2007.09.038

Schultz-Cherry S, 2000, Virology, 278, 55, 10.1006/viro.2000.0635

Laust AK, 2007, Breast Cancer Res Treat, 106, 371, 10.1007/s10549-007-9517-8

Moran TP, 2007, Vaccine, 25, 6604, 10.1016/j.vaccine.2007.06.058

10.1006/viro.1998.9367

10.1016/S0264-410X(01)00353-X

10.1371/journal.pone.0012670

Durso RJ, 2007, Clin Cancer Res, 13, 3999, 10.1158/1078-0432.CCR-06-2202

Sheahan T, 2011, J Virol, 85, 217, 10.1128/JVI.01805-10

10.1128/JVI.74.1.371-378.2000

Johnston RE, 2005, Vaccine, 23, 4969, 10.1016/j.vaccine.2005.05.034

Davis NL, 2002, IUBMB Life, 53, 209, 10.1080/15216540212657

Lee JS, 2002, J Infect Dis, 185, 1192, 10.1086/339677

Vander Veen RL, 2012, Vaccine, 30, 1944, 10.1016/j.vaccine.2012.01.030

Hooper JW, 2009, Vaccine, 28, 494, 10.1016/j.vaccine.2009.09.133